Home / Products / Pharma / General / By Brand Name / Zirgan


Ganciclovir USP

Zirgan 0.15% w/w 5 gm Eye gel


Zirgan Eye Gel (Ganciclovir) which is an anti-viral guanosine derivative. Indicated for the treatment of acute herpetic keratitis (dendritic ulcers). Zirgan is available as 5 gm sterile eye gel.

Zirgan Eye Gel: Each gram eye gel contains Ganciclovir USP 1.5 mg.

Zirgan 0.15% is indicated for the treatment of acute herpetic keratitis (dendritic ulcers).

v  Not more than 20 ml should be prescribed at a time.

Most common adverse reactions reported in patients are blurred vision (60%), eye irritation (20%), punctate keratitis (5%), and conjunctival hyperemia (5%).

Zirgan is indicated for topical ophthalmic use only. Patients should not wear contact lenses if they have signs or symptoms of herpetic keratitis or during the course of therapy with Zirgan.

Pregnancy category C; There are no adequate and well-controlled studies in pregnant women. Zirgan should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Lactation: It is not known whether topical ophthalmic Ganciclovir administration could result in sufficient systemic absorption to produce detectable quantities in breast milk. Caution should be exercised when Zirgan is administered to nursing mothers.

Store at 15°C-25°C. Do not freeze.

None to date available

Zirgan Eye Gel: Each tube contains 5 gm sterile eye gel.